WOK
WORK Medical Technology Group LTD
Next earnings Aug 17, 2026
$2.11
▼ -4.52%$2.11▼ -100.00%
over 1Y
L $2.11H $911,999.90
Our buy Our hold Our sell Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today
-4.5%
1W
-0.5%
1M
-71.9%
3M
—
YTD
—
1Y
—
Avoid
Conviction
Horizon
Medium (3–12mo)
Conservative balance sheet (liabilities/equity 0.65x); but revenue fell -14.4% YoY.
Revenue (FY2025) $9.85M · FY2025
This call stands until the filings change it — the engine re-rates on new 10-K/10-Q/8-K facts, never on price moves. Hit Watch above to follow WOK (Pro alerts fire the moment a rating flips), or catch every change in Saturday’s Flip Side. How to read a call
WORK Medical Technology Group LTD shows $9.85M in FY2025 revenue (-14.4% YoY), a -10.9% net margin, and -5.8% ROE.
Supporting the case: conservative balance sheet (liabilities/equity 0.65x).
Is WOK a buy? The one-page verdict, explained →
The options angle
model · matches our verdictBear put spread (caution)~60d expiry
- Long put 2 @ ~1.05 est
- Short put 2 @ ~1.05 est
debit $0max +$0max $0
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
Financialsannual, by fiscal year
| Line item | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|
| Revenue | $19.7M | $13.6M | $11.5M | $9.85M |
| Gross profit | $4.42M | $4.14M | $2.87M | $2.34M |
| Operating income | — | — | — | — |
| Net income | $865K | $112K | -$3.49M | -$1.07M |
| Diluted EPS | $0.07 | $0.01 | -$0.27 | -$0.04 |
| Net margin | 4.4% | 0.8% | -30.4% | -10.9% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$7.41M
EV / EBITDA—
EV / Sales0.8
EV / FCF1.5
P / FCF1.0
PEG (trailing)—
Earnings yield-21.0%
FCF yield96.3%
Quality & risk
ROIC (est.)—
Free cash flow$4.91M
Total debt$6.39M
Net cash-$2.30M
Piotroski F-Score4/8
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+128.1%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Recent filings
all on EDGAR ↗4Period ending 2026-06-102026-06-23open ↗4Period ending 2026-06-102026-06-17open ↗SCHEDULE 13G/AFiling2026-06-16open ↗4Period ending 2026-06-102026-06-16open ↗4Period ending 2026-06-102026-06-12open ↗3Period ending 2026-06-102026-06-12open ↗4Period ending 2026-06-042026-06-10open ↗SCHEDULE 13G/AFiling2026-06-10open ↗4Period ending 2026-06-042026-06-09open ↗SCHEDULE 13G/AFiling2026-06-09open ↗4Period ending 2026-06-042026-06-08open ↗3Period ending 2026-06-042026-06-08open ↗
Frequently asked
- Is WORK Medical Technology Group LTD (WOK) a buy?
- WOK currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.65x); but revenue fell -14.4% YoY.
- What is WORK Medical Technology Group LTD's quality score?
- WOK scores 50.0629357073655/100 (grade C-) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0001929783, latest 4 filed 2026-06-23) · EODHD · as of 7/7/2026, 3:02:13 PM.
About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice
Rule-based analysis, generated automatically from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 7, 2026, 11:02 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.